FDA official: generative AI medical tools may be evaluated like physicians, not devices

nlarusstone · x · 2026-10-22

Rick Abramson, radiologist and director of FDA's Digital Health Center of Excellence, said at the AdvaMed MedTech Conference that generative AI medical tools may need to be assessed more like a physician's ongoing competency reviews than traditional software.

Original post →

More from Safety

Safety channel →